1271 Share Price Performance
Recent 1271 News & Updates
No updates
SunWay Biotech Co., LTD. Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 1.96
- Gross Margin
- 56.18%
- Net Profit Margin
- 12.22%
- Debt/Equity Ratio
- 0%
SunWay Biotech Co., LTD. Competitors
About 1271
- Founded
- 2007
- Employees
- n/a
- CEO
- WebsiteView website
SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan.
Taiwanese Market Performance
- 7 Days: 0.3%
- 3 Months: 12.3%
- 1 Year: 6.6%
- Year to Date: 2.0%
In the last week, the market has stayed flat, however the Energy sector stood out, gaining 7.6%. Meanwhile, the market is actually up 6.6% over the past year. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading